CureDM

About:

CureDM is a biopharmaceutical company developing therapies that can prevent, ameliorate and reverse diabetes.

Top Investors: Scientific Health Development Partners, Calvert Research Institute

Description:

CureDM is a biopharmaceutical company established to develop new therapies that may prevent, ameliorate or reverse diabetes and allow for the discontinuation of insulin.

Total Funding Amount:

$4.6M

Headquarters Location:

Wilmington, Delaware, United States

Founded Date:

2004-01-01

Contact Email:

contact(AT)curedm.com

Founders:

Claresa Levetan, Loraine Upham, Rita El-Hajj

Number of Employees:

1-10

Last Funding Date:

2009-08-10

IPO Status:

Private

Industries: